Skip to main content
. 2019 Apr 6;69(6):2489–2501. doi: 10.1002/hep.30519

Figure 5.

Figure 5

Serum AKR1B10 in detection of early‐stage HCC. (A) Training cohort: ROC curves for early‐stage HCC versus all controls (left); ROC curves for early‐stage HCC versus high‐risk controls (CHB + LC) (middle); positive rates for AKR1B10, AFP, or both in HCC and for AKR1B10 by AFP status (right). (B) Validation cohort: ROC curves for early‐stage HCC versus all controls (left); ROC curves for early‐stage HCC versus high‐risk controls (CHB + LC) (middle); positive rates for AKR1B10, AFP, or both in HCC and for AKR1B10 by AFP status (right).